Effects of antihistamines on 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats

Synapse

Volumn 33, Issue 3, 1999, Pages 207-217

  Yeh, S Y ^a,b   Dersch, C ^a   Rothman, R ^a   Cadet, J L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NIDA Addiction Research Center   (United States)

Author keywords

Antihistamine; Chlorpheniramine; Diphenhydramin e; Hyperthermia; MDMA; Neurotoxicity; Pyrilamine; Tripelennamine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ANTIHISTAMINIC AGENT; CHLORPHENIRAMINE; DIPHENHYDRAMINE; MEPYRAMINE; NISOXETINE; PAROXETINE; TRIPELENNAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN SYNAPTOSOME; DOPAMINE UPTAKE; DRUG EFFECT; DRUG POTENTIATION; HYPERTHERMIA; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONIN UPTAKE;

EID: 0033198041     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8     Document Type: Article

References (46)

1. 3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916.
2. Berger UV, Gu XF, Azmitia EC. 1992. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153-160.
3. Boja JW, Kuhar MJ, Kopajtic T, Yang E, Abraham P, Lewin AH, Carrol FI. 1995. Secondary amine analogues of 3-β-(4′-substituted phenyl) tropane-2β-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. J Med Chem 37:1220-1230.
4. Broening HW, Bowyer JF, Slikker W Jr. 1995. Age-dependent sensitivity of rats to long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethylamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275:325-333.
5. Brown PA, Vernikos J. 1980. Antihistamines effect on synaptosomal uptake of serotonin, norepinephrine and dopamine. Eur J Pharmacol 65:89-92.
6. Cadet JL, Ladenheim B, Baum I, Carlson E, Epstein C. 1994. CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Brain Res 655: 259-262.
7. Cadet JL, Ladenheim B, Hirata H, Rothman RB, Ali S, Carlson E, Epstein C. 1995. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice. Synapse 21:169-176.
8. Carlsson A, Lindqvist M. 1969. Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J Pharm Pharmacol 21:460-464.
9. Che S, Johnson M, Hanson GR, Gibb JW. 1995. Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur J Pharmacol 293:447-453.
10. Chiueh CC, Wu R-M, Mohanakumar KP, Sternberger LM, Frishna T, Obata T, Murphy DL. 1994. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. In the neurobiology of NO• and •OH. Ann NY Acad Sci 738:15-25.
11. Clausing P, Newport GD, Bowyer JF. 1998. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain. J Pharmacol Exp Ther 284:618-624.
12. Colado MI, Murray TK, Green AR. 1993. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br J Pharmacol 108:583-589.
13. Colado MI, O'Shea E, Granados R, Murray TK, Green AR. 1997. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889-900.
14. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster ER, Seiden LS. 1987. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338-345.
15. Cusimano VJ, Sankar DVS. 1977. Uptake and release of 5-hydroxytryptamine by rabbit platelets. II. Kinetic analysis of inhibition by chlorpheniramine maleate. Biochem Med 17:267-274.
16. Dixon WJ, Brown MB, Engelman L, Jennrich RL. 1990. BMDP statistical software manual. Berkeley: University of California Press.
17. Elayan I, Gibb JW, Hanson GR, Lim HK, Foltz RL, Johnson M. 1993. Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity. J Pharmacol Exp Ther 265:813-817.
18. Farfel GM, Seiden LS. 1995. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J Pharmacol Exp Ther 272:860-867.
19. Fuller RW, Snoddy HD, Molly BB. 1975. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors. Psychopharmacol Commun 1:455-464.
20. 3H]-DOPA in various regions of the brain. J Neurochem 13:655-659.
21. Hardman HF, Haavik CO, Seevers MH. 1973. Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals. Toxicol Appl Pharmacol 25:299-309.
22. Henry JA, Jeffreys KJ, Dawling S. 1992. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 340:384-387.
23. Hiramatsu M, Kumagai Y, Unger SE, Cho AK. 1990. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J Pharmacol Exp Ther 254:521-527.
24. Hiroi T, Ohishi N, Imaoka S, Yabusaki Y, Fukui H, Funae Y. 1995. Mepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rats and human P4502D forms. J Pharmacol Exp Ther 272:939-944.
25. Holtzman JL, Carr ML. 1972. The temperature dependence of the components of the hepatic microsomal mixed-function oxidases. Arch Biochem Biophys 150:227-234.
26. Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB. 1989. 3,4-Methylenenedioxymethamphetamine ("Ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 249:713-720.
27. Kalser SC, Kelvington EJ, Randolph MM, Santonmenna DM. 1965. Drug metabolism in hypothermia. II. C14 atropine uptake, metabolism and excretion by the isolated perfused rat liver. J Pharmacol Exp Ther 147:260-269.
28. Kil YH, Zhang J, Piantadosi CA. 1996. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J Cerebral Blood Metab 16:100-106.
29. Kuhn DM, Arthur R Jr. 1998. Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons. J Neurosci 15:7111-7117.
30. 2 production during ischemia and reperfusion: a microdialysis study in the gerbil hippocampus. Neurosci Lett 222:91-94.
31. Lowry OH, Roserbrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
32. Malberg JE, Sabot KE, Seiden LS. 1996. Coadministration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278:258-267.
33. McNamara MG, Kelly JP, Leonard BE. 1995. The effect of acute MDMA administration on body temperature, serum corticosterone and neurotransmitter concentrations in male and female rats. Human Psychopharmacol 10:373-383.
34. McPherson GA. 1988. Kinetic, EBDA, Ligand, Lowry: a collection of radioligand binding analysis programs. Amsterdam: Elsevier.
35. Meek JL, Fuxe K, Carlsson A. 1971. Blockade of p-chloromethamphetamine induced 5-hydroxytryptamine depletion by chlorimipramine, chlorpheniramine and meperidine. Biochem Pharmacol 20:707-709.
36. Miller DB, O'Callaghan JP. 1994. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
37. Nash KF Jr, Meltzer HY, Gudelsky GA. 1988. Elevation of serum prolactin and cortisone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245:873-879.
38. 1-antihistamines. Pol J Pharmacol Pharm 37:147-162.
39. Rehman A, Whiteman M, Halliwell B. 1997. Scavenging of hydroxyl radicals but not peroxynitrite by inhibitors and substrates of nitric oxide syntheses. Br J Pharmacol 122:1072-1705.
40. Rothman RB, Lewis B, Dersch C, Xu H, Radesca L, de Costa BR, Rice KC, Kilburn RB, Akunne HC, Pert A. 1993. Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14:34-39.
41. Schmidt CJ. 1987. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7.
42. Stone DM, Stahl DC, Hanson GR, Gibb JW. 1986. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128:41-48.
43. Yeh SY. 1997a. The effect of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Pharmacol Biochem Behav 58:701-708.
44. Yeh SY. 1997b. Chlorpheniramine protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats. Neurosci Abstr 27:21-41.
45. Yeh SY. 1999a. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats. Synapse 31:169-177.
46. Yeh, SY. 1999b. Effects of antihistamines on fenfluramiine-induced depletion of indoles in the brain of rats. Synapse, 32:301-311.